• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与多基因形式的糖尿病相比,肝细胞核因子1A-成熟型糖尿病青年发病型(HNF1A-MODY)和葡萄糖激酶-成熟型糖尿病青年发病型(GCK-MODY)患者的循环胃饥饿素水平更高。

Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus.

作者信息

Nowak Natalia, Hohendorff Jerzy, Solecka Iwona, Szopa Magdalena, Skupien Jan, Kiec-Wilk Beata, Mlynarski Wojciech, Malecki Maciej T

机构信息

Department of Metabolic Diseases, Jagiellonian University Medical College, 15 Kopernika Street, 31-501, Krakow, Poland.

Section on Genetics and Epidemiology, Joslin Diabetes Center, Boston, MA, USA.

出版信息

Endocrine. 2015 Dec;50(3):643-9. doi: 10.1007/s12020-015-0627-5. Epub 2015 May 19.

DOI:10.1007/s12020-015-0627-5
PMID:25987348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4662709/
Abstract

Ghrelin is a hormone that regulates appetite. It is likely to be involved in the pathophysiology of varying forms of diabetes. In animal studies, the ghrelin expression was regulated by the hepatocyte nuclear factor 1 alpha (HNF1A). Mutations of the HNF1A gene cause maturity onset diabetes of the young (MODY). We aimed to assess the circulating ghrelin levels in HNF1A-MODY and in other types of diabetes and to evaluate its association with HNF1A mutation status. Our cohort included 46 diabetic HNF1A gene mutation carriers, 55 type 2 diabetes (T2DM) subjects, 42 type 1 diabetes (T1DM) patients, and 31 glucokinase (GCK) gene mutation carriers with diabetes as well as 51 healthy controls. Plasma ghrelin concentration was measured using the immunoenzymatic assay with polyclonal antibody against the C-terminal fragment of its acylated and desacylated forms. Ghrelin concentrations were 0.75 ± 0.32, 0.70 ± 0.21, 0.50 ± 0.20, and 0.40 ± 0.16 ng/ml in patients with HNF1A-MODY, GCK-MODY, T1DM, and T2DM, respectively. The ghrelin levels were higher in HNF1A-MODY and GCK-MODY than in T1DM and T2DM (p < 0.001 for all comparisons) but lower than in non-diabetic controls (1.02 ± 0.29 ng/ml, p < 0.001 for both comparisons). In the multivariate linear model, the differences between both MODY groups and common diabetes types remained significant. Analysis by a HNF1A mutation type indicated that ghrelin concentration is similar in patients with different types of sequence differences. Plasma ghrelin level is higher in HNF1A-MODY and GCK-MODY than in the common polygenic forms of diabetes.

摘要

胃饥饿素是一种调节食欲的激素。它可能参与了不同类型糖尿病的病理生理过程。在动物研究中,胃饥饿素的表达受肝细胞核因子1α(HNF1A)调控。HNF1A基因突变会导致青年发病的成年型糖尿病(MODY)。我们旨在评估HNF1A-MODY患者及其他类型糖尿病患者的循环胃饥饿素水平,并评估其与HNF1A突变状态的关联。我们的队列包括46名携带HNF1A基因突变的糖尿病患者、55名2型糖尿病(T2DM)患者、42名1型糖尿病(T1DM)患者、31名携带糖尿病相关葡萄糖激酶(GCK)基因突变的患者以及51名健康对照者。使用针对其酰化和去酰化形式C末端片段的多克隆抗体通过免疫酶测定法测量血浆胃饥饿素浓度。HNF1A-MODY患者、GCK-MODY患者、T1DM患者和T2DM患者的胃饥饿素浓度分别为0.75±0.32、0.70±0.21、0.50±0.20和0.40±0.16 ng/ml。HNF1A-MODY和GCK-MODY患者的胃饥饿素水平高于T1DM和T2DM患者(所有比较p<0.001),但低于非糖尿病对照者(1.02±0.29 ng/ml,两个比较均p<0.001)。在多变量线性模型中,两种MODY组与常见糖尿病类型之间的差异仍然显著。按HNF1A突变类型分析表明,不同类型序列差异患者的胃饥饿素浓度相似。HNF1A-MODY和GCK-MODY患者的血浆胃饥饿素水平高于常见的多基因形式糖尿病患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b57/4662709/039392b506dd/12020_2015_627_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b57/4662709/c07777825291/12020_2015_627_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b57/4662709/039392b506dd/12020_2015_627_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b57/4662709/c07777825291/12020_2015_627_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b57/4662709/039392b506dd/12020_2015_627_Fig2_HTML.jpg

相似文献

1
Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus.与多基因形式的糖尿病相比,肝细胞核因子1A-成熟型糖尿病青年发病型(HNF1A-MODY)和葡萄糖激酶-成熟型糖尿病青年发病型(GCK-MODY)患者的循环胃饥饿素水平更高。
Endocrine. 2015 Dec;50(3):643-9. doi: 10.1007/s12020-015-0627-5. Epub 2015 May 19.
2
Intima-media thickness and endothelial dysfunction in GCK and HNF1A-MODY patients.葡萄糖激酶和肝细胞核因子 1A 成年发病型糖尿病患者的内中膜厚度和内皮功能障碍。
Eur J Endocrinol. 2015 Mar;172(3):277-83. doi: 10.1530/EJE-14-0713. Epub 2014 Dec 10.
3
A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.单剂量达格列净(一种钠-葡萄糖协同转运蛋白2抑制剂)在葡萄糖激酶和肝细胞核因子1α介导的成年发病型糖尿病中诱导的糖尿症高于2型糖尿病。
Endocrine. 2017 Aug;57(2):272-279. doi: 10.1007/s12020-017-1341-2. Epub 2017 Jun 7.
4
HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.高密度脂蛋白胆固醇作为儿童和青年人群中 GCK-MODY 与 HNF1A-MODY 及 1 型糖尿病临床鉴别诊断的工具。
Clin Endocrinol (Oxf). 2011 Sep;75(3):321-7. doi: 10.1111/j.1365-2265.2011.04052.x.
5
Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing.一个年轻起病的成年型糖尿病(MODY)家系中 HNF1a 和 GCK 突变的共同遗传:对基因检测的意义。
Clin Endocrinol (Oxf). 2013 Sep;79(3):342-7. doi: 10.1111/cen.12050. Epub 2013 Apr 1.
6
Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations.突尼斯青年发病型成年糖尿病(MODY):葡萄糖激酶(GCK)和肝细胞核因子1α(HNF1A)突变的低频率
Gene. 2018 Apr 20;651:44-48. doi: 10.1016/j.gene.2018.01.081. Epub 2018 Feb 3.
7
Quality of life assessment in patients with HNF1A-MODY and GCK-MODY.评估 HNF1A-MODY 和 GCK-MODY 患者的生活质量。
Endocrine. 2019 May;64(2):246-253. doi: 10.1007/s12020-018-1812-0. Epub 2018 Nov 12.
8
A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations.一种用于识别因 HNF1A 突变而患有单基因糖尿病高概率患者的决策算法。
Endocrine. 2019 Apr;64(1):75-81. doi: 10.1007/s12020-019-01863-7. Epub 2019 Feb 18.
9
Lower Circulating miR-122 Level in Patients with HNF1A Variant-Induced Diabetes Compared with Type 2 Diabetes.与 2 型糖尿病相比,HNF1A 变异诱导的糖尿病患者循环 miR-122 水平较低。
J Diabetes Res. 2018 Aug 1;2018:7842064. doi: 10.1155/2018/7842064. eCollection 2018.
10
Three unreported glucokinase (GCK) missense mutations detected in the screening of thirty-two Brazilian kindreds for GCK and HNF1A-MODY.在对32个巴西家族进行葡萄糖激酶(GCK)和肝细胞核因子1α(HNF1A)-成年发病型糖尿病(MODY)筛查时检测到3个未报道的葡萄糖激酶(GCK)错义突变。
Diabetes Res Clin Pract. 2014 Nov;106(2):e44-8. doi: 10.1016/j.diabres.2014.08.006. Epub 2014 Aug 12.

引用本文的文献

1
Monogenic diabetes: An evidence-based clinical approach.单基因糖尿病:基于证据的临床方法。
World J Diabetes. 2025 May 15;16(5):104787. doi: 10.4239/wjd.v16.i5.104787.
2
Monogenic Defects of Beta Cell Function: From Clinical Suspicion to Genetic Diagnosis and Management of Rare Types of Diabetes.单基因β细胞功能缺陷:从临床疑诊到罕见类型糖尿病的遗传学诊断和管理。
Int J Mol Sci. 2024 Sep 29;25(19):10501. doi: 10.3390/ijms251910501.
3
Unraveling the genetic basis of MODY: insights from next-generation sequencing.解析青少年发病的成年型糖尿病的遗传基础:来自新一代测序的见解

本文引用的文献

1
Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases.胃饥饿素和六肽生长激素释放肽在糖尿病及糖尿病相关心脏病中的意义。
Endocrine. 2015 Jun;49(2):307-23. doi: 10.1007/s12020-015-0531-z. Epub 2015 Feb 4.
2
Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans.外源性给予的生长激素释放肽在生理浓度下可减少健康人群的胰岛素分泌,而不影响胰岛素敏感性。
J Clin Endocrinol Metab. 2013 Jun;98(6):2536-43. doi: 10.1210/jc.2012-4162. Epub 2013 Apr 15.
3
Mutations in HNF1A result in marked alterations of plasma glycan profile.
J Appl Genet. 2025 May;66(2):375-381. doi: 10.1007/s13353-024-00907-7. Epub 2024 Oct 3.
4
Germline and conditional ghrelin knockout increases islet size.胚系和条件性生长激素释放肽敲除增加胰岛大小。
J Clin Invest. 2023 Dec 15;133(24):e175799. doi: 10.1172/JCI175799.
5
Meta-analysis across Nellore cattle populations identifies common metabolic mechanisms that regulate feed efficiency-related traits.对 Nellore 牛群体的荟萃分析确定了调节与饲料效率相关性状的常见代谢机制。
BMC Genomics. 2022 Jun 7;23(1):424. doi: 10.1186/s12864-022-08671-w.
6
Precision diabetes: Lessons learned from maturity-onset diabetes of the young (MODY).精准糖尿病:从青少年起病的成年型糖尿病(MODY)中吸取的经验教训。
J Diabetes Investig. 2022 Sep;13(9):1465-1471. doi: 10.1111/jdi.13860. Epub 2022 Jun 16.
7
HNF1A Mutations and Beta Cell Dysfunction in Diabetes.HNF1A 突变与糖尿病中的β细胞功能障碍。
Int J Mol Sci. 2022 Mar 16;23(6):3222. doi: 10.3390/ijms23063222.
8
A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY.一项关于 HNF1A-MODY 最常见因果变异体表型后果的多代研究。
Diabetologia. 2022 Apr;65(4):632-643. doi: 10.1007/s00125-021-05631-z. Epub 2021 Dec 24.
9
"A LEAP 2 conclusions? Targeting the ghrelin system to treat obesity and diabetes".“LEAP 2 研究结论?靶向 ghrelin 系统治疗肥胖和糖尿病”。
Mol Metab. 2021 Apr;46:101128. doi: 10.1016/j.molmet.2020.101128. Epub 2020 Nov 25.
10
Ghrelin Protects Against Insulin-Induced Hypoglycemia in a Mouse Model of Type 1 Diabetes Mellitus.生长激素释放肽可预防 1 型糖尿病小鼠模型的胰岛素诱导性低血糖。
Front Endocrinol (Lausanne). 2020 Sep 11;11:606. doi: 10.3389/fendo.2020.00606. eCollection 2020.
HNF1A 基因突变导致血浆聚糖谱明显改变。
Diabetes. 2013 Apr;62(4):1329-37. doi: 10.2337/db12-0880. Epub 2012 Dec 28.
4
Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.载脂蛋白 M 可区分 HNF1A-MODY 与 1 型糖尿病。
Diabet Med. 2013 Feb;30(2):246-50. doi: 10.1111/dme.12066.
5
Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release.生长激素释放肽受体信号的改变受生长抑素受体 5 的调节,可控制胰岛素的释放。
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):19003-8. doi: 10.1073/pnas.1209590109. Epub 2012 Oct 29.
6
Ghrelin O-acyltransferase assays and inhibition.胃饥饿素O-酰基转移酶测定与抑制
Methods Enzymol. 2012;514:205-28. doi: 10.1016/B978-0-12-381272-8.00013-1.
7
Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans.未酰化 ghrelin 夜间持续输注对人体的代谢影响。
Eur J Endocrinol. 2012 May;166(5):911-6. doi: 10.1530/EJE-11-0982. Epub 2012 Feb 29.
8
A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.一项大型多中心欧洲研究证实了高敏 C 反应蛋白 (hsCRP) 作为糖尿病亚型诊断的临床生物标志物的有效性。
Diabetologia. 2011 Nov;54(11):2801-10. doi: 10.1007/s00125-011-2261-y. Epub 2011 Aug 4.
9
Stress-related alterations of acyl and desacyl ghrelin circulating levels: mechanisms and functional implications.应激相关的酰基和去酰基 ghrelin 循环水平的改变:机制和功能意义。
Peptides. 2011 Nov;32(11):2208-17. doi: 10.1016/j.peptides.2011.07.002. Epub 2011 Jul 12.
10
Ghrelin in Type 2 diabetes mellitus and metabolic syndrome.生长激素释放肽在 2 型糖尿病及代谢综合征中的作用。
Mol Cell Endocrinol. 2011 Jun 20;340(1):26-8. doi: 10.1016/j.mce.2011.02.009. Epub 2011 Mar 23.